The SETIA program examined the economic impact of typhoid illness and evaluated the potential value of introducing typhoid conjugate vaccine (TCV) into Indonesia’s National Immunisation Program.
A multisite cost-of-illness study estimated the direct and indirect costs associated with typhoid